When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNOM - 4 Genomic Companies With Upcoming Catalysts
Global X Genomics & Biotechnology ETF
Alnylam specializes in commercialized and in-pipeline RNA interference (RNAi) therapeutics.
Sarepta’s commercial portfolio focuses on Duchenne muscular dystrophy (DMD), a genetic disorder of progressive muscular weakness, typically in young boys.
BioMarin is a commercial stage biotech firm, with six FDA-approved therapies in the market.
CRISPR is a pre-revenue, clinical stage biotech firm that focuses on gene editing via CRISPR/Cas9 technology.